NYSE:LII • US5261071071
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LENNOX INTERNATIONAL INC (LII).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-03-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2026-01-29 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-16 | JP Morgan | Maintains | Underweight -> Underweight |
| 2026-01-07 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-05 | UBS | Reiterate | Neutral -> Neutral |
| 2025-12-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-13 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2025-10-27 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-23 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-23 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-10-17 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-10-15 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-06 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-09-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-16 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.982B 5.58% | 5.341B 7.21% | 5.195B -2.73% | 5.554B 6.90% | 5.87B 5.69% | 6.203B 5.67% | 7.68B 23.81% | 8.286B 7.89% | 8.295B 0.11% | 8.71B 5.00% | |
| EBITDA YoY % growth | 892.3M 22.32% | 1.136B 27.30% | 1.166B 2.66% | 1.253B 7.45% | 1.346B 7.42% | 1.454B 8.02% | 1.797B 23.59% | 1.949B 8.46% | N/A | N/A | |
| EBIT YoY % growth | 806.3M 23.74% | 1.041B 29.08% | 1.054B 1.23% | 1.135B 7.73% | 1.226B 8.02% | 1.322B 7.83% | 1.669B 26.25% | 1.813B 8.63% | N/A | N/A | |
| Operating Margin | 16.18% | 19.49% | 20.28% | 20.44% | 20.89% | 21.31% | 21.73% | 21.88% | N/A | N/A | |
| EPS YoY % growth | 17.98 27.61% | 22.58 25.58% | 22.62 0.18% | 24.42 7.97% | 26.84 9.91% | 29.49 9.87% | 39.52 34.01% | 43.71 10.61% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.21 -4.83% | 7.73 -1.09% | 7.63 9.35% | 5.84 31.26% | 4.30 34.15% | 8.90 15.13% | 8.36 9.57% | 6.63 13.54% |
| Revenue Q2Q % growth | 1.082B 0.88% | 1.555B 3.60% | 1.576B 10.46% | 1.402B 17.32% | 1.217B 12.48% | 1.704B 9.58% | 1.653B 4.89% | 1.475B 5.21% |
| EBITDA Q2Q % growth | 186.85M 2.22% | 384.06M -4.37% | 377.96M -2.18% | 299.74M -14.97% | 223.97M 19.87% | 430.11M 11.99% | 391.38M 3.55% | 321.33M 7.20% |
| EBIT Q2Q % growth | 158.88M 1.07% | 356.61M 2.12% | 351.24M 14.41% | 272.79M 13.66% | 196.04M 23.39% | 402.33M 12.82% | 363.45M 3.48% | 293.41M 7.56% |
All data in USD
24 analysts have analysed LII and the average price target is 569.09 USD. This implies a price increase of 11.18% is expected in the next year compared to the current price of 511.86.
LENNOX INTERNATIONAL INC (LII) will report earnings on 2026-04-21, before the market open.
The consensus EPS estimate for the next earnings of LENNOX INTERNATIONAL INC (LII) is 3.21 USD and the consensus revenue estimate is 1.08B USD.
The consensus rating for LENNOX INTERNATIONAL INC (LII) is 69.1667 / 100 . This indicates that analysts generally have a neutral outlook on the stock.